These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4388629)

  • 21. [Orthostatic hypotensive disorders in a neuropsychiatric department. Their correction by Praxinor].
    Pluvinage R
    Therapeutique; 1973 Nov; 49(9):561-4. PubMed ID: 4151908
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
    Mott TF; Leach L; Johnson L
    J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
    [No Abstract]   [Full Text] [Related]  

  • 23. [Paradoxical effect of methylphenidate in the treatment of a patient with severe traumatic brain injury].
    Grønborg P; Liljegren J; Jansen J
    Ugeskr Laeger; 2009 Jun; 171(26):2201-2. PubMed ID: 19671403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial of pemoline in general practice.
    Kagan G
    Br J Clin Pract; 1974 Nov; 28(11):375-8. PubMed ID: 4618123
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possible connection between eating disorders and ADHD. Bulimia can relieve ADHD symptoms, central nervous stimulants are of good help].
    Ersson G; Klanger AR; Wallsten T; Nilsson KW; Lindström L
    Lakartidningen; 2007 May 2-8; 104(18):1402-5. PubMed ID: 17550013
    [No Abstract]   [Full Text] [Related]  

  • 27. Compliance with stimulant medications in patients with narcolepsy.
    Rogers AE; Aldrich MS; Berrios AM; Rosenberg RS
    Sleep; 1997 Jan; 20(1):28-33. PubMed ID: 9130331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
    Rikkert MG
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2416; author reply 2416-7. PubMed ID: 15615278
    [No Abstract]   [Full Text] [Related]  

  • 29. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation].
    Zetterström R
    Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF; Vergnaud S; Mouren MC
    Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemoline augmentation for resistant depression.
    Benazzi F
    J Psychiatry Neurosci; 1997 Jan; 22(1):71. PubMed ID: 9002395
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic management of daytime sleepiness.
    Schwartz JR
    J Clin Psychiatry; 2004; 65 Suppl 16():46-9. PubMed ID: 15575805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of magnesium pemoline and methylphenidate on memory improvement and mood in normal aging subjects.
    Gilbert JG; Donnelly KJ; Zimmer LE; Kubis JF
    Int J Aging Hum Dev; 1973; 4(1):35-51. PubMed ID: 4591659
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of methylphenidate in traumatic brain injury.
    Siddall OM
    Ann Pharmacother; 2005; 39(7-8):1309-13. PubMed ID: 15914519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of psychoneurosis by medazepam--with special reference to therapy of disorders of autonomic nervous system].
    Toru M; Shimazono Y
    Saishin Igaku; 1971 Mar; 26(3):553-62. PubMed ID: 4926344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.